SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3w3s'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1FBM_B_RTLB951_2
(PROTEIN (CARTILAGE
OLIGOMERIC MATRIX
PROTEIN))
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 4 THR A 138
LEU A 137
VAL A 155
LEU A 158
None
0.93A 1fbmD-3w3sA:
undetectable
1fbmD-3w3sA:
7.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ONI_F_BEZF511_0
(14.5 KDA
TRANSLATIONAL
INHIBITOR PROTEIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 5 TYR A 323
GLU A 368
PHE A 409
ALA A 317
None
SSA  A2002 ( 2.5A)
PT  A2004 (-0.7A)
SSA  A2002 (-4.4A)
1.40A 1oniE-3w3sA:
0.0
1oniF-3w3sA:
0.0
1oniE-3w3sA:
12.29
1oniF-3w3sA:
12.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XDK_E_9CRE1500_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 12 ALA A  76
ALA A  77
LEU A  38
VAL A  26
LEU A  11
None
1.05A 1xdkE-3w3sA:
undetectable
1xdkE-3w3sA:
19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Z9H_D_IMND476_1
(MEMBRANE-ASSOCIATED
PROSTAGLANDIN E
SYNTHASE-2)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 12 ILE A  65
VAL A   9
ILE A  61
VAL A  80
LEU A  99
None
1.17A 1z9hD-3w3sA:
undetectable
1z9hD-3w3sA:
19.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ZZR_B_H4BB761_1
(NITRIC-OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.24A 1zzrA-3w3sA:
undetectable
1zzrB-3w3sA:
undetectable
1zzrA-3w3sA:
23.27
1zzrB-3w3sA:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2DTT_C_H4BC1002_1
(HYPOTHETICAL PROTEIN
PH0634)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 6 ASP A 328
PHE A 464
THR A 255
GLU A 324
None
1.37A 2dttB-3w3sA:
undetectable
2dttC-3w3sA:
undetectable
2dttB-3w3sA:
12.38
2dttC-3w3sA:
12.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q9R_A_BEZA203_0
(PROTEIN OF UNKNOWN
FUNCTION)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 5 LEU A  11
GLY A  95
ILE A  22
ILE A  61
None
C  B  56 ( 3.2A)
None
None
0.83A 2q9rA-3w3sA:
undetectable
2q9rA-3w3sA:
18.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2QD4_B_CHDB928_0
(FERROCHELATASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 12 LEU A   3
PHE A   5
LEU A 108
LEU A 158
VAL A 122
None
1.39A 2qd4B-3w3sA:
undetectable
2qd4B-3w3sA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2W3B_B_FOLB401_1
(DIHYDROFOLATE
REDUCTASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
3 / 3 GLU A 440
GLN A 493
ARG A 191
None
0.85A 2w3bB-3w3sA:
undetectable
2w3bB-3w3sA:
14.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3DQR_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.16A 3dqrA-3w3sA:
undetectable
3dqrB-3w3sA:
undetectable
3dqrA-3w3sA:
23.19
3dqrB-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX2_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.22A 3jx2A-3w3sA:
undetectable
3jx2B-3w3sA:
undetectable
3jx2A-3w3sA:
23.19
3jx2B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_A_H4BA760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 VAL A 129
ARG A 103
VAL A 107
GLU A 131
None
1.26A 3jx3A-3w3sA:
undetectable
3jx3B-3w3sA:
undetectable
3jx3A-3w3sA:
23.19
3jx3B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.24A 3jx3A-3w3sA:
undetectable
3jx3B-3w3sA:
undetectable
3jx3A-3w3sA:
23.19
3jx3B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.22A 3jx4A-3w3sA:
undetectable
3jx4B-3w3sA:
undetectable
3jx4A-3w3sA:
23.19
3jx4B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX5_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.20A 3jx5A-3w3sA:
undetectable
3jx5B-3w3sA:
undetectable
3jx5A-3w3sA:
23.19
3jx5B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3JX6_B_H4BB761_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.25A 3jx6A-3w3sA:
undetectable
3jx6B-3w3sA:
undetectable
3jx6A-3w3sA:
23.19
3jx6B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LOQ_A_ACTA278_0
(UNIVERSAL STRESS
PROTEIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
3 / 3 SER A 449
GLY A 451
SER A 405
SSA  A2002 (-3.1A)
SSA  A2002 (-3.4A)
None
0.56A 3loqA-3w3sA:
undetectable
3loqA-3w3sA:
20.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NLP_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.21A 3nlpA-3w3sA:
undetectable
3nlpB-3w3sA:
undetectable
3nlpA-3w3sA:
23.19
3nlpB-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S3V_A_TOPA193_1
(DIHYDROFOLATE
REDUCTASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 5 LEU A 398
ILE A 505
PRO A 504
PHE A 231
None
1.21A 3s3vA-3w3sA:
undetectable
3s3vA-3w3sA:
15.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX3_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.24A 4cx3A-3w3sA:
undetectable
4cx3B-3w3sA:
undetectable
4cx3A-3w3sA:
23.19
4cx3B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CX4_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.23A 4cx4A-3w3sA:
undetectable
4cx4B-3w3sA:
undetectable
4cx4A-3w3sA:
23.19
4cx4B-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4K87_A_ADNA602_1
(PROLINE--TRNA LIGASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 8 ARG A 349
ARG A 360
PHE A 364
GLY A 451
ARG A 485
SSA  A2002 (-3.0A)
None
SSA  A2002 ( 3.5A)
SSA  A2002 (-3.4A)
SSA  A2002 ( 3.7A)
1.14A 4k87A-3w3sA:
22.6
4k87A-3w3sA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M6T_A_SAMA201_0
(RNA POLYMERASE
II-ASSOCIATED FACTOR
1 HOMOLOG, LINKER,
RNA
POLYMERASE-ASSOCIATE
D PROTEIN LEO1)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 4 ILE A 367
VAL A 450
VAL A 483
ARG A 229
None
SSA  A2002 (-4.8A)
None
None
0.96A 4m6tA-3w3sA:
undetectable
4m6tA-3w3sA:
15.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4M7T_A_SAMA503_0
(BTRN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 11 THR A  25
LEU A  88
LEU A  13
SER A  14
ARG A  15
None
None
None
C  B  56 ( 3.5A)
None
1.45A 4m7tA-3w3sA:
undetectable
4m7tA-3w3sA:
15.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4MJR_A_0LAA404_1
(DNA POLYMERASE III
SUBUNIT BETA)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 9 GLY A 471
LEU A 474
PRO A 333
VAL A 331
VAL A 466
None
1.44A 4mjrA-3w3sA:
undetectable
4mjrA-3w3sA:
23.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OLB_A_TRPA901_0
(PROTEIN ARGONAUTE-2)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
3 / 3 VAL A 370
ALA A 479
PHE A 242
None
0.89A 4olbA-3w3sA:
undetectable
4olbA-3w3sA:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_B_RTZB602_1
(CYTOCHROME P450 2D6)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 12 PHE A 242
GLY A 451
ALA A 388
VAL A 402
VAL A 455
None
SSA  A2002 (-3.4A)
None
None
None
1.13A 4wnwB-3w3sA:
undetectable
4wnwB-3w3sA:
22.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XQE_A_AG2A506_1
(HOMOSPERMIDINE
SYNTHASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 6 ARG A 109
ARG A 112
ASP A 111
VAL A 135
None
SO4  A2020 (-3.3A)
SO4  A2020 (-4.0A)
None
1.13A 4xqeA-3w3sA:
undetectable
4xqeA-3w3sA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XQE_B_AG2B505_1
(HOMOSPERMIDINE
SYNTHASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 6 ARG A 109
ARG A 112
ASP A 111
VAL A 135
None
SO4  A2020 (-3.3A)
SO4  A2020 (-4.0A)
None
1.15A 4xqeB-3w3sA:
undetectable
4xqeB-3w3sA:
22.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XQG_A_AG2A505_1
(HOMOSPERMIDINE
SYNTHASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 8 ARG A 109
ARG A 112
ASP A 111
VAL A 135
None
SO4  A2020 (-3.3A)
SO4  A2020 (-4.0A)
None
1.14A 4xqgA-3w3sA:
undetectable
4xqgA-3w3sA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XQG_B_AG2B505_1
(HOMOSPERMIDINE
SYNTHASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 8 ARG A 109
ARG A 112
ASP A 111
VAL A 135
None
SO4  A2020 (-3.3A)
SO4  A2020 (-4.0A)
None
1.14A 4xqgB-3w3sA:
undetectable
4xqgB-3w3sA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XZK_A_AG2A700_1
(PUTATIVE
NAD(+)--ARGININE
ADP-RIBOSYLTRANSFERA
SE VIS)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 SER A 405
ARG A 485
SER A 449
GLU A 430
None
SSA  A2002 ( 3.7A)
SSA  A2002 (-3.1A)
None
1.41A 4xzkA-3w3sA:
undetectable
4xzkA-3w3sA:
18.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Z4I_A_IPHA903_0
(PROTEIN ARGONAUTE-2)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
3 / 3 VAL A 370
ALA A 479
PHE A 242
None
0.88A 4z4iA-3w3sA:
2.7
4z4iA-3w3sA:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5B2Q_A_ACTA1728_0
(CRISPR-ASSOCIATED
ENDONUCLEASE CAS9)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
3 / 3 ASN A 454
SER A 452
ARG A 366
SSA  A2002 (-4.3A)
SSA  A2002 (-2.9A)
SSA  A2002 (-3.0A)
0.77A 5b2qA-3w3sA:
undetectable
5b2qA-3w3sA:
14.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5G0P_B_H4BB760_1
(NITRIC OXIDE
SYNTHASE, BRAIN)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 7 GLU A 131
VAL A 129
ARG A 103
VAL A 107
None
1.21A 5g0pA-3w3sA:
undetectable
5g0pB-3w3sA:
undetectable
5g0pA-3w3sA:
23.19
5g0pB-3w3sA:
23.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWK_A_BEZA301_0
(GLUTATHIONE-SPECIFIC
GAMMA-GLUTAMYLCYCLOT
RANSFERASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 10 GLY A 301
SER A 302
LEU A 303
LEU A 289
GLU A 288
None
1.00A 5hwkA-3w3sA:
undetectable
5hwkA-3w3sA:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5HWK_B_BEZB301_0
(GLUTATHIONE-SPECIFIC
GAMMA-GLUTAMYLCYCLOT
RANSFERASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 10 GLY A 301
SER A 302
LEU A 303
LEU A 289
GLU A 288
None
1.00A 5hwkB-3w3sA:
undetectable
5hwkB-3w3sA:
18.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQD_A_RIOA600_0
(BIFUNCTIONAL AAC/APH)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 11 SER A  53
SER A   6
GLU A   8
GLU A  64
VAL A  80
None
1.42A 5iqdA-3w3sA:
0.0
5iqdA-3w3sA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IQD_C_RIOC600_0
(BIFUNCTIONAL AAC/APH)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 12 SER A  53
SER A   6
GLU A   8
GLU A  64
VAL A  80
None
1.40A 5iqdC-3w3sA:
undetectable
5iqdC-3w3sA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5JS1_A_IPHA902_0
(PROTEIN ARGONAUTE-2)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
3 / 3 VAL A 370
ALA A 479
PHE A 242
None
0.87A 5js1A-3w3sA:
1.2
5js1A-3w3sA:
20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5X7Z_A_BHAA201_0
(UNCHARACTERIZED
HTH-TYPE
TRANSCRIPTIONAL
REGULATOR RV2887)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
4 / 6 LEU A 435
VAL A 433
LEU A 398
VAL A 450
None
None
None
SSA  A2002 (-4.8A)
0.75A 5x7zA-3w3sA:
0.9
5x7zA-3w3sA:
14.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BNI_A_ADNA602_1
(LYSINE--TRNA LIGASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 10 ARG A 349
GLU A 351
PHE A 364
GLY A 482
ARG A 485
SSA  A2002 (-3.0A)
SSA  A2002 (-3.2A)
SSA  A2002 ( 3.5A)
SSA  A2002 (-2.8A)
SSA  A2002 ( 3.7A)
0.84A 6bniA-3w3sA:
9.8
6bniA-3w3sA:
9.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BNI_B_ADNB602_1
(LYSINE--TRNA LIGASE)
3w3s TYPE-2 SERINE--TRNA
LIGASE

(Methanopyrus
kandleri)
5 / 10 ARG A 349
GLU A 351
PHE A 364
GLY A 482
ARG A 485
SSA  A2002 (-3.0A)
SSA  A2002 (-3.2A)
SSA  A2002 ( 3.5A)
SSA  A2002 (-2.8A)
SSA  A2002 ( 3.7A)
0.84A 6bniB-3w3sA:
10.6
6bniB-3w3sA:
9.30